Signum Biosciences Company
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Total Funding:
$55M
Headquarters:
Boulder, Colorado, United States
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Debt
Technology:
Data-driven Technologies
Investors Number:
1
Founded Date:
2004
Industry:
PharmTech